|
SEGMENT INFORMATION (Details) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2012
|
Sep. 30, 2012
|
Jun. 30, 2012
|
Mar. 31, 2012
|
Dec. 31, 2011
|
Sep. 30, 2011
|
Jun. 30, 2011
|
Mar. 31, 2011
|
Dec. 31, 2012
segment
|
Dec. 31, 2011
|
Dec. 31, 2010
|
|
| Segment information | |||||||||||
| Number of reportable segments | 3 | ||||||||||
| Segment information | |||||||||||
| Net sales | $ 3,325,836 | $ 3,222,884 | $ 2,818,040 | ||||||||
| Total net sales | 784,692 | 813,502 | 867,713 | 859,929 | 673,601 | 929,636 | 831,711 | 787,936 | 3,325,836 | 3,222,884 | 2,818,040 |
| Transaction related costs, restructuring and other, net | 38,833 | 3,271 | 102 | ||||||||
| Gain on sale of assets | (19,250) | (1,150) | |||||||||
| Long-lived asset impairment charges (recoveries), net | (824) | 8,318 | |||||||||
| Operating income | 67,633 | 73,922 | 28,400 | 68,255 | (1,967) | 54,415 | 35,510 | 36,641 | 238,210 | 124,599 | 114,269 |
| Depreciation and amortization | 89,857 | 101,522 | 99,691 | ||||||||
| Capital expenditures | 80,338 | 66,382 | 45,714 | ||||||||
| Total assets | 1,801,315 | 1,644,211 | 1,801,315 | 1,644,211 | 1,665,701 | ||||||
|
Chlorovinyls
|
|||||||||||
| Segment information | |||||||||||
| Net sales | 1,344,908 | 1,318,678 | 1,224,724 | ||||||||
| Intersegment revenues | 236,043 | 235,683 | 245,977 | ||||||||
| Total net sales | 1,580,951 | 1,554,361 | 1,470,701 | ||||||||
| Transaction related costs, restructuring and other, net | 1,259 | 521 | (340) | ||||||||
| Gain on sale of assets | (19,250) | (1,150) | |||||||||
| Operating income | 237,214 | 143,304 | 114,297 | ||||||||
| Depreciation and amortization | 45,163 | 56,014 | 59,524 | ||||||||
| Capital expenditures | 44,739 | 37,059 | 22,810 | ||||||||
| Total assets | 966,405 | 874,646 | 966,405 | 874,646 | 953,756 | ||||||
|
Aromatics
|
|||||||||||
| Segment information | |||||||||||
| Net sales | 1,104,290 | 1,020,307 | 799,676 | ||||||||
| Total net sales | 1,104,290 | 1,020,307 | 799,676 | ||||||||
| Operating income | 64,569 | 10,370 | 23,335 | ||||||||
| Depreciation and amortization | 1,533 | 1,483 | 1,405 | ||||||||
| Capital expenditures | 2,699 | 1,637 | 2,641 | ||||||||
| Total assets | 180,124 | 121,331 | 180,124 | 121,331 | 140,941 | ||||||
|
Building Products
|
|||||||||||
| Segment information | |||||||||||
| Number of primary product groups | 2 | ||||||||||
| Segment information | |||||||||||
| Net sales | 876,638 | 883,899 | 793,639 | ||||||||
| Intersegment revenues | 447 | 3 | 140 | ||||||||
| Total net sales | 877,085 | 883,902 | 793,779 | ||||||||
| Transaction related costs, restructuring and other, net | 1,504 | 2,750 | 442 | ||||||||
| Long-lived asset impairment charges (recoveries), net | (824) | 8,318 | |||||||||
| Operating income | 18,447 | 7,500 | 14,554 | ||||||||
| Depreciation and amortization | 38,414 | 39,658 | 33,695 | ||||||||
| Capital expenditures | 24,947 | 23,843 | 20,263 | ||||||||
| Total assets | 604,532 | 606,442 | 604,532 | 606,442 | 554,016 | ||||||
|
Eliminations, Unallocated and Other
|
|||||||||||
| Segment information | |||||||||||
| Intersegment revenues | (236,490) | (235,686) | (246,117) | ||||||||
| Total net sales | (236,490) | (235,686) | (246,117) | ||||||||
| Transaction related costs, restructuring and other, net | 36,070 | ||||||||||
| Operating income | (82,020) | (36,575) | (37,917) | ||||||||
| Depreciation and amortization | 4,747 | 4,367 | 5,067 | ||||||||
| Capital expenditures | 7,953 | 3,843 | |||||||||
| Total assets | $ 50,254 | $ 41,792 | $ 50,254 | $ 41,792 | $ 16,988 | ||||||